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Abstract
Background: Neuroinvasion of Venezuelan equine encephalitis virus (VEEV) and subsequent initiation of
inflammation in the brain plays a crucial role in the outcome of VEEV infection in mice. Adhesion molecules
expressed on microvascular endothelial cells in the brain have been implicated in the modulation of the blood
brain barrier (BBB) and inflammation in brain but their role in VEEV pathogenesis is not very well understood. In
this study, we evaluated the expression of extracellular matrix and adhesion molecules genes in the brain of VEEV
infected mice.
Findings: Several cell to cell adhesion molecules and extracellular matrix protein genes such as ICAM-1, VCAM-1,
CD44, Cadherins, integrins, MMPs and Timp1 were differentially regulated post-VEEV infection. ICAM-1 knock-out
(IKO) mice infected with VEEV had markedly reduced inflammation in the brain and demonstrated a delay in the
onset of clinical symptoms of disease. A differential regulation of inflammatory genes was observed in the IKO
mice brain compared to their WT counterparts.
Conclusions: These results improve our present understanding of VEEV induced inflammation in mouse brain.
Findings
Neurovirulent Venezuelan equine encephalitis virus
(VEEV) is a member of the genus Alphavirus,i nt h e
family Togaviridae. VEEV causes lethal encephalitis in
equines and occasionally infect humans [1,2]. In our ear-
lier studies, we have reported upregulation of several
integrins (Itg) and integrin binding molecule genes such
as nischarin (Nisch) and integrin alpha V (ItgaV) as well
as genes that are implicated in the alteration of the
blood brain barrier (BBB) such as MCP-1 [3] in the
brains of VEEV infected mice [4,5]. Other studies have
also shown that adhesion molecules expressed on the
surface of microvascular endothelial cells of the BBB
play an important role in viral encephalitis [6,7]. VEEV
replicon particles have also been recently reported to
disrupt BBB [8]. Though, VEEV has been known to
enter the central nervous system (CNS) through the
olfactory tract, these studies indicate that adhesion
molecules expressed on the BBB may also play role in
VEEV pathogenesis [2]. Therefore, in this study, we
evaluated the expression of extracellular matrix (ECM)
and adhesion molecules in VEEV infected CD-1 mice
brain. Several ECM and adhesion molecules genes, such
as integrins (ItgaX ,I t g 2 ,3 ,a n d7 ) ,c a d h e r i n( C d h )1
and 2, intracellular adhesion molecule-1 (ICAM-1), and
vascular cell adhesion molecule (VCAM-1) were found
to be upregulated in the brains of VEEV infected CD-1
mice (Table 1). Immunohistochemistry analysis showed
ICAM-1 expression and its co-localization with inflam-
mation, fibrinogen leakage and VEEV antigen in and
around the brain microvessels (Figure 1). Pathway analy-
sis of the modulated ECM and adhesion molecules
genes using DAVID software [9,10] indicated their
involvement in leukocyte migration at BBB (Additional
f i l e1F i g u r eS 1 ) .O ft h e s es e v e r a lg e n e s ,I C A M - 1h a s
been implicated in the pathogenesis of various other
neurotropic viruses such as West Nile virus, Semliki
Forest virus, Theiler’s murine encephalomyelitis virus
and lymphocyte choriomeningitis virus [11-14]. To test
if ICAM-1 plays any role in VEEV pathogenesis, ICAM-
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Functional Grouping (Gene) Fold expression over uninfected controls
48 hr pi 72 hr pi 96 hr pi 120 hr pi
Cell Adhesion molecules: Transmembrane/cell-cell adhesion/cell-matrix adhesion/other molecules
9 NM_009851 CD44 antigen (Cd44) (A) 5.24 (PI) ± 4.24 (0.37) 16.35 (PI) ± 10.09 (0.20) 34.83 (PI) ± 3.23 (0.0004)
10 NM_009864 Cadherin 1 (Cdh1) 3.97 ± 0.32 (0.0007) 4.98 ± 3.37 (0.30) 6.52 ± 5.23 (0.35) 16.79 ± 1.57 (0.0005)
14 NM_009868 Cadherin 5 (Cdh5) (A) 1.17 (PI) ± 0.17 (0.37) 1.92 (PI) ± 0.59(0.19) 9.57 (PI) ± 0.97 (0.0009)
29 NM_016919 Procollagen, type V, alpha 3 (Col5a3) 0.81 ± 0.15 (0.51) 1.09 ± 0.19 (0.78) 1.60 ± 0.67 (0.16) 2.07 ± 0.31 (0.03)
32 NM_007739 Procollagen, type VIII, alpha 1 (Col8a1) 1.41 ± 0.49 (0.53) 1.77 ± 1.31(0.27) 1.18 ± 0.39 (0.70) 0.80 ± 0.61 (0.65)
34 XM_488510/
NM_001081249.1
Mus musculus chondroitin sulfate proteoglycan 2(Cspg2)/
Versican (Vcan)
1.14 ± 0.40 (0.74) 2.36 ± 0.80 (0.28) 3.34 ± 1.13 (0.23) 4.39 ± 1.83 (0.07)
35 NM_010217 Connective tissue growth factor (Ctgf) 0.88 ± 0.13 (0.38) 0.91 ± 0.13 (0.52) 0.83 ± 0.05 (0.24) 0.45 ± 0.10 (0.01)
38 NM_009848 Ectonucleoside triphosphate diphosphohydrolase 1(Entpd1) (A) (A) (A) 4.37 (PI) ± 1.41 (0.03)
41 NM_013500 Hyaluronan and proteoglycan link protein 1 (Hapln1) 0.67 (PI) ± 0.29 1.15 (PI) ± 0.13 (0.73) (A) (A)
43 NM_010493 Intercellular adhesion molecule (Icam1) 2.82 (PI) ± 1.32 (0.24) 8.4 (PI) ± 3.00 (0.07) 13.51 (PI) ± 6.24 (0.12) 36.76 (PI) ± 4.81 (0.001)
56 NM_021334 Integrin alpha × (Itgax) (A) (A) 4.49 ± 1.12 (0.01) 3.55 (PI) ± 0.89 (0.02)
57 NM_010578 Integrin beta 1 (fibronectin receptor beta) (Itgb1) 1.06 ± 0.48 (0.83) 1.61 ± 0.35 (0.27) 2.41 ± 0.56 (0.02) 2.67 ± 0.39 (0.01)
58 NM_008404 Integrin beta 2 (Itgb2) (A) (A) (A) 4.79 (PI) ± 0.27 (0.0.0001)
59 NM_016780 Integrin beta 3 (Itgb3) 1.36 (PI) ± 0.25 (0.59) 2.32 (PI) ± 0.30 (0.10) 3.37 (PI) ± 1.32 (0.03) 3.06 (PI) ± 0.55 (0.01)
63 NM_013566 Integrin beta 7 (Itgb7) 0.83 ± 0.13 (0.50) (A) 3.40 ± 1.98 (0.27) 7.84 (PI) ± 3.04 (0.04)
96 NM_011346 Selectin, lymphocyte (Sell) 2.67 (PI) ± 0.89 (0.33) 10.06 (PI) ± 5.41 (0.08) 20.37(PI) ± 11.02 (0.07) 21.45 (PI) ± 5.60 (0.001)
97 NM_011347 Selectin, platelet (Selp) 12.66 (PI) ± 8.84 (0.26) 32.57 (PI) ± 2.66
(0.0002)
43.14 (PI) ± 5.70 (0.001) 37.60 (PI) ± 4.37 (0.001)
105 NM_011581 Thrombospondin 2 (Thbs2) 1.17 ± 0.34 (0.58) 1.60 ± 0.82 (0.44) 2.87 ± 1.58 (0.40) 4.02 ± 3.50 (0.39)
107 NM_011582 Thrombospondin 4 (Thbs4) 11.99 ± 3.25 (0.03) 2.70 ± 1.19 (0.22) 1.30 ± 0.30 (0.37) (A)
Extracellular Matrix Proteins: Basement membrane constituents/ECM proteases and their inhibitors/others
5 NM_013906 A disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 8 (Adamts8)
(A) 2.44 (PI) ± 0.34 (0.01) (A) 2.78 (PI) ± 0.41 (0.01)
16 NM_007729 Procollagen, type XI, alpha 1 (Col11a1) (A) 2.60 ± 1.61(0.37) (A) (A)
77 NM_008608 Matrix metallopeptidase 14 (membrane-inserted) (Mmp14) 0.51 ± 0.09 (0.05) 1.07 ± 0.12 (0.76) 1.32 ± 0.28 (0.11) 1.24 ± 0.20 (0.17)
78 NM_008609 Matrix metallopeptidase 15 (Mmp15) (A) (A) 2.48 ± 1.48 (0.37) (A)
79 NM_019724 Matrix metallopeptidase 16 (Mmp16) 0.49 ± 0.16 (0.09) 1.62 ± 0.07 (0.22) 0.68 ± 0.26 (.035) 1.18 ± 0.32 (0.65)
87 NM_010809 Matrix metallopeptidase 3 (Mmp3) 4.60 (PI) ± 3.34 (0.34) 29.25 (PI) ± 8.41 (0.03) 48.06 (PI) ± 2.98
(0.00009)
26.60 (PI) ± 5.76 (0.01)
89 NM_008611 Matrix metallopeptidase 8 (Mmp8) 1.21 ± 0.29 (0.46) (A) 6.15 ± 4.73 (0.38) 22.59 (PI) ± 6.94 (0.05)
101 NM_009263 Secreted phosphoprotein 1 (Spp1) 1.00 ± 0.03 (0.99) 0.67 ± 0.18 (0.12) 0.63 ± 0.17 (0.12) 0.50 ± 0.06 (0.01)
103 NM_009369 Transforming growth factor, beta induced (Tgfbi) 0.87 ± 0.10 (0.40) 0.55 ± 0.19 (0.15) 0.06 ± 0.04 (0.001) 0.08 ± 0.06 (0.001)
108 NM_011593 Tissue inhibitor of metalloproteinase 1 (Timp1) (A) 4.88 (PI) ± 2.38 (0.18) 17.64 (PI) ± 5.88 (0.05) 13.79 (PI) ± 1.36 (0.0007)
112 NM_011607 Tenascin C (Tnc) (A) (A) 0.49 ± 0.25 (0.37) (A)




















































































9Figure 1 ICAM-1 expression corresponds with perivascular cuffing, fibrinogen leakage, and the presence of VEEV in the brains of
VEEV infected mice. (a) H&E staining of the brain of VEEV infected CD-1 mice exhibited prominent perivascular cuffs throughout the brain. (b)
Endothelial cells are hypertrophied and exhibit positive immunoreactivity for ICAM-1. (c) Immunohistochemistry for fibrinogen demonstrated
localized fibrinogen leakage around hypertrophied endothelial cells, indicating disruption of the BBB. (d) Extensive VEEV specific staining revealed
numerous cells infected with VEEV around the affected vessels. (e) Perivascular cuffs were composed of moderate numbers of mononuclear cells,
primarily lymphocytes and fewer monocytes which had transmigrated the endothelium and multifocally extended into the neuropil. (f) Neurons
were primarily infected with VEEV; however, VEEV antigen was also localized in glia and fewer lymphocytes. (g) Vacuolation of the neuropil was
observed around the affected vessels.
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Page 3 of 91 knockout (IKO) mice (B6.129S4-Icam1tm1Jcgr/J, stock
No. 002867, Jackson Laboratories, Bar Harbor, Maine,
USA) were infected with 1000 pfu of VEEV in two sepa-
rate studies. In both these studies, VEEV infected wild
type (WT; C57BL/6J, stock No. 000664, Jackson Labora-
tories, Bar Harbor, Maine, USA) mice became sick ear-
lier than the ICAM-1 knock-out (IKO) mice. IKO mice
showed delayed appearance of the clinical symptoms
such as shivering, excitability, and hind limb paralysis
with a total loss of mobility. General health and appear-
ance of the WT mice evaluated as ruffled fur, hunched
back posture and lethargy in the early stages of the dis-
ease was severe than similarly infected IKO mice. IKO
mice were more responsive to touch, less lethargic and
were eating better than the WT mice. Though a 20%
reduction in mortality was observed in both the studies
(Figure 2), there was no difference in the mean survival
time of the IKO mice that succumbed to VEEV infec-
tion as compared to the WT mice. Histopathological
analysis of brain showed less severe single cell necrosis
and perivascular cuffing in the IKO mice brain than the
WT mice at 96 hr post infection (pi) (Figure 3). How-
ever, no significant difference in VEEV antigen was
noticed (data not shown) in the brains of IKO and WT
mice. The inflammatory cytokine specific focused micro-
array performed on the brain RNA samples of VEEV
infected WT and IKO mice at 96 hr pi (Table 2) showed
inflammatory gene expression differences in the brain of
IKO mice. Basal level differences in the cytokine expres-
sion of uninfected IKO and WT brain are given in
additional file 2 Table S1. Microarray analysis (Table 2)
showed a complex inflammatory response to VEEV
infection in the brain of IKO mice which can be classi-
fied based on pro- and anti-inflammatory response and
may explain some of the differences seen early in the
infection of IKO and WT mice. Several pro-inflamma-
tory cytokines/ligands such as Ccl24, Cxcl11 and Cxcl13
were down regulated in IKO mice brain as compared to
WT mice. Ccr2, a chemokine receptor that is involved
in the migration of peripheral blood mononuclear cells
into the brain [15] was also down regulated in the
brains of VEEV infected IKO mice. Anti-inflammatory
genes IL10, Ccl22 and IL22 were also down regulated in
the brains of VEEV infected IKO mice. These cytokines
and chemokines have been implicated in the regulation
and suppression of inflammation in the tissues [16-19].
Other pro-inflammatory genes such as Ccr1 and Xcl1
that have been implicated in the recruitment of mono-
nuclear phagocytes and T cells respectively into the
brain [20-23] were either upregulated or induced in the
VEEV infected IKO mice brain. Modulation of these
anti-inflammatory and pro-inflammatory genes may
contribute to the final outcome of inflammation
observed in the brain of VEEV infected IKO mice. Gene
expression evaluation at early and later time points than
96 hr pi may shed more light on the inflammatory gene
expression kinetics in the brain of IKO mice. To further
evaluate if inflammation is crucial, animals were treated
with a known anti-inflammatory drug naproxen (40 mg/
kg, once a day). Similar to the VEEV infected IKO mice,
Figure 2 Survival study in IKO mice. Representative of two separate survival studies done in IKO mice upon VEEV infection is shown here.
Mice were observed twice a day for fourteen days pi for signs of clinical disease. There was a 20% reduction in mortality in IKO mice over their
WT controls in both the studies.
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Page 4 of 9Figure 3 Inflammation in the brain of VEEV infected IKO and WT mice. (a) IKO 96 hr pi cerebrum, subventricular zone, H&E, 400X: There
were low numbers of necrotic neurons, characterized by small amounts of karyorrhexis (arrows), when compared to the same region of the WT
mice (b). (b) WT 96n hr pi, cerebrum, subventricular zone, H&E, 400X: There were high numbers of necrotic neurons, characterized by large
amounts of karyorrhexis (arrows), when compared to the same region of IKO mice (a). (c) IKO 96 hr pi, brainstem, H&E, 400X: There was little to
no endothelial swelling and no perivascular cuffing (arrows) compared to the WT mice (d). (d) WT 96 hr pi, brainstem, H&E, 400X: There was
moderate endothelial swelling and mild perivascular cuffing (thick arrows) and rare necrotic cells (thin arrow) compared to the IKO mice (c). (e)
IKO 96 hr pi, brain, thalamus, H&E, 400X: There was little to no endothelial swelling and no perivascular cuffing (arrows) compared to the WT
mice (f). (f) WT 96 hr pi, brain, thalamus, H&E, 400X: There was moderate endothelial swelling and mild perivascular cuffing (thick arrow) and rare
necrotic cells (thin arrows) compared to the IKO mice (e).
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Page 5 of 9naproxen treated VEEV infected CD-1 mice (n = 10) early
in the infection (0-5 days) showed lesser degree of ruffled
fur, lethargy, hunched back, and delayed appearance of
shivering and paralysis as compared to the untreated mice
(n = 10), thereafter, these mice quickly became sick and
there was no difference in the mean survival time of
naproxen treated and untreated VEEV infected mice. A
marked decrease but not total ablation in the vascular
inflammation was observed in the naproxen treated
VEEV-infected mice at 96 and 120 hr pi (n = 3 each
group) (Figure 4). Viral load in the brain was evaluated by
RT-PCR at 48, 72, 96 and 120 hr pi (n = 5 each group).
There was no significant difference in the viral load in the
brain of the naproxen treated and untreated VEEV
infected mice groups. However, when taken as individual
sets of mice, more viral load was observed in the brain of
some of the naproxen treated mice as compared to the
untreated ones (Figure 5). Treatment with ribavirin
(80 mg/kg, once a day), a known anti-viral drug, alone or
in combination with naproxen also did not affect the mor-
tality or the viral load in VEEV infected mice. These
results show a complex role of inflammation in VEEV
pathology, initial better health of naproxen treated mice
may be due to reduced inflammation in the brain. How-
ever, increase in brain viral load in naproxen treated ani-
mals may be due to unchecked viral replication due to
reduced inflammation.
To our knowledge, this is the first study to evaluate the
expression of ECM and adhesion molecules in brain
during VEEV infection and to evaluate the inflammatory
response in IKO mice during VEEV infection. The
results show that adhesion molecules such as ICAM-1
may play an important role in VEEV disease pathology.
These findings improve our present understanding of
VEEV induced inflammation in the mouse brain and its
implication in VEEV disease.
Table 2 Differential gene expression in brains of VEEV infected ICAM-1 WT mice (n = 3) as compared to IKO mice (n =
3) at 96 hr pi.
Position RefSeq
Number





7 NM_011332 Ccl17 Chemokine (C-C motif) ligand 17 (Ccl17) 73.57 (A) P-IKO
13 NM_019577 Ccl24 Chemokine (C-C motif) ligand 24 (Ccl24) (A) 273.69 POR P-WT
22 NM_009912 Ccr1 Chemokine (C-C motif) receptor 1 (Ccr1) 132.24 ± (40.75) 28.80 POR 4.59
35 NM_019494 Cxcl11 Chemokine (C-X-C motif) ligand 11 (Cxcl11) 435.04 ± (167.36) 690.98 ± (322.64) 0.63
37 NM_018866 Cxcl13 Chemokine (C-X-C motif) ligand 13 (Cxcl13) 163.29 POR 245.09 ± (156.61)
PTwR
0.67





51 NM_010548 Il10 Interleukin 10 (Il10) (A) 57.40 ± (43.51) PTwR P-WT
68 NM_008362 Il1r1 Interleukin 1 receptor, type I (Il1r1) 119.93 POR (A) P-IKO
69 NM_010555 Il1r2 Interleukin 1 receptor, type II (Il1r2) 287.27 POR 172.19 ± (94.76)
PTwR
1.67
73 NM_016971 Il22 Interleukin 22 (Il22) (A) 186.84 POR P-WT
74 NM_008368 Il2rb Interleukin 2 receptor, beta chain (Il2rb) 151.12 POR 31.83 POR 4.75
93 NM_011101 Prkca Protein kinase C, alpha (Prkca) 60.8 POR (A) P-IKO





95 NM_007926 Scye1 Small inducible cytokine subfamily E, member 1
(Scye1)
385.53 ± (137.18) 243.61 ± (159.47) 1.58
96 NM_009263 Spp1 Secreted phosphoprotein 1 (Spp1) 693.01 ± (74.26) 389.60 ± (127.58) 1.78
104 NM_133211 Tlr7 Toll-like receptor 7 (Tlr7) 176.40 ± (87.47)
PTwR
35.74 ± (22.32) PTwR 4.94
107 NM_013693 Tnf Tumor necrosis factor (Tnf) 74.90 ± (8.85) PTwR 193.78 POR 0.39
112 NM_008510 Xcl1 Chemokine (C motif) ligand 1 (Xcl1) 76.09 ± (42.81)
PTwR
(A) P-IKO
Average expression values of gene are given. Where gene expression was detected in only one biological sample and not the replicates, the gene expression
value is followed by POR (present in one replicate), similarly where the gene expression was detected in two biological replicates the gene expression value is
followed by PTwR (present in two replicates). The fold expression values are derived by dividing average expression (or expression value from one or two
replicates) of VEEV infected IKO samples with average expression (or expression value from one replicate) of VEEV infected ICAM WT samples and vice versa. PI =
Expressed only in VEEV infected samples, PC = Expressed in uninfected saline control samples only, (A) = absent. Values are expressed as ± SEM.
Sharma et al. Virology Journal 2011, 8:197
http://www.virologyj.com/content/8/1/197
Page 6 of 9Figure 4 Inflammation was reduced in VEEV infected mice treated with naproxen or naproxen plus ribavirin. Animals were treated with
naproxen (40 mg/kg/once a day) only or naproxen plus ribavirin (80 mg/kg/once a day) at the time of infection (1000 pfu of VEEV inoculated in
left rear foot pad). Animals were monitored twice a day and clinical symptoms of disease were monitored for two weeks.
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Page 7 of 9Additional material
Additional file 1: Figure S1: Functional pathway analysis of
adhesion molecules expressed in the brain of VEEV infected mice.
All the ECM protein and adhesion molecule genes that were differentially
modulated in the brains of VEEV infected mice were subjected to
pathway analysis by DAVID software functional annotation tool. The
genes that are circled in red were differentially regulated in this study.
The diagram shows their location and involvement in leukocyte
transendothelial migration at tight junctions.
Additional file 2: Table S1: Differential gene expression in the brain
of uninfected, saline injected WT mice (n = 2) as compared to
uninfected, saline injected IKO mice (n = 2). Average expression
values of each gene are given. Where gene expression was detected in
only one biological sample and not the replicates, the gene expression
value is followed by POR (present in one replicate). The fold expression
values are derived by dividing average (or expression value from one
replicate) expression of IKO controls with average (or expression value
from one replicate) expression of ICAM-1 WT (WT) samples. P-IKO =
Expressed only in IKO samples only, P-WT = present in WT samples only,
(A) = absent. Values are expressed as ± SEM.
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